Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Depending on the exchange, the stock ticker may vary. For instance, on exchange Aspen Pharmacare stocks are traded under the ticker LDZA.MU.
When is the next Aspen Pharmacare earnings date?▼
Aspen Pharmacare is going to release the next earnings report on September 02, 2026.
What were Aspen Pharmacare earnings last quarter?▼
LDZA.MU earnings for the last quarter are 0.32 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Aspen Pharmacare have?▼
As of April 12, 2026, the company has 8,580 employees.
In which sector is Aspen Pharmacare located?▼
Aspen Pharmacare operates in the Health & Wellness sector.
When did Aspen Pharmacare complete a stock split?▼
Aspen Pharmacare has not had any recent stock splits.
Where is Aspen Pharmacare headquartered?▼
Aspen Pharmacare is headquartered in Durban, South Africa.